Paul L. Berns, Director at Jazz Pharmaceuticals plc (JAZZ), sold 1,450 shares at $154.00 ($223K) on 2021-08-05, disclosed to the SEC on 2021-08-09.
Seasonal sale ($223k) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NMRA | SELL | 2026-02-19 | $34K | — | Filing → |
| NMRA | SELL | 2025-02-20 | $23K | — | Filing → |
| MTSR | BUY | 2025-02-03 | $14.2M | — | Filing → |